One health and resistant fungi: a challenging balancing act between food security and patient survival

  23 March 2026

The article highlights that azole-resistant Aspergillus fumigatus is an escalating global health threat driven by both medical and agricultural azole use, leading to the emergence and environmental spread of resistant strains that undermine first-line antifungal therapies. It emphasizes that resistance arises through genetic mutations (notably in cyp51A) via two main routes—patient treatment and environmental exposure—resulting in reduced treatment efficacy and increased mortality. The paper further stresses major gaps in rapid diagnostics, surveillance, and awareness, arguing for improved detection methods, stewardship across clinical and agricultural sectors, and coordinated One Health strategies to contain the spread and safeguard future antifungal effectiveness.

Further reading: Taylor & Francis Online
Author(s): M. Lackner et al
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!